JP2006506942A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506942A5
JP2006506942A5 JP2003563456A JP2003563456A JP2006506942A5 JP 2006506942 A5 JP2006506942 A5 JP 2006506942A5 JP 2003563456 A JP2003563456 A JP 2003563456A JP 2003563456 A JP2003563456 A JP 2003563456A JP 2006506942 A5 JP2006506942 A5 JP 2006506942A5
Authority
JP
Japan
Prior art keywords
amino acid
peptide
seq
acid sequence
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003563456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006506942A (ja
Filing date
Publication date
Priority claimed from US10/235,852 external-priority patent/US20040052928A1/en
Application filed filed Critical
Priority claimed from PCT/IL2003/000079 external-priority patent/WO2003063760A2/en
Publication of JP2006506942A publication Critical patent/JP2006506942A/ja
Publication of JP2006506942A5 publication Critical patent/JP2006506942A5/ja
Pending legal-status Critical Current

Links

JP2003563456A 2002-01-31 2003-01-30 アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法 Pending JP2006506942A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35257802P 2002-01-31 2002-01-31
US39226602P 2002-07-01 2002-07-01
US10/235,852 US20040052928A1 (en) 2002-09-06 2002-09-06 Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US43645302P 2002-12-27 2002-12-27
PCT/IL2003/000079 WO2003063760A2 (en) 2002-01-31 2003-01-30 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases

Publications (2)

Publication Number Publication Date
JP2006506942A JP2006506942A (ja) 2006-03-02
JP2006506942A5 true JP2006506942A5 (de) 2006-04-13

Family

ID=27671045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003563456A Pending JP2006506942A (ja) 2002-01-31 2003-01-30 アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法

Country Status (6)

Country Link
EP (1) EP1534310A4 (de)
JP (1) JP2006506942A (de)
KR (1) KR20040081165A (de)
AU (1) AU2003207973A1 (de)
CA (1) CA2473987C (de)
WO (1) WO2003063760A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040052928A1 (en) 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US7781396B2 (en) 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
EP1583713B1 (de) 2003-01-07 2009-03-25 Ramot at Tel Aviv University Ltd. Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
CA2530927A1 (en) 2003-06-30 2005-01-06 Tel Aviv University Future Technology Development L.P. Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
EP1781310B1 (de) 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Artikel von peptidnanostrukturen und herstellungsverfahren dafür
WO2007043048A2 (en) 2005-10-11 2007-04-19 Ramot At Tel Aviv University Ltd. Self-assembled fmoc-ff hydrogels
WO2007126111A1 (ja) 2006-04-28 2007-11-08 Kagoshima University アミロイドβ線維化阻害ペプチド
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
EP2560953B1 (de) 2010-04-21 2016-01-06 Probiodrug AG Hemmer der glutaminylzyklase
RU2013124827A (ru) 2010-10-29 2014-12-10 Мерц Фарма Гмбх Унд Ко. Кгаа Производные индола и способ их получения
WO2012066549A1 (en) 2010-11-15 2012-05-24 Ramot At Tel-Aviv University Ltd. Dipeptide analogs for treating conditions associated with amyloid fibril formation
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
CN112225808A (zh) 2012-09-12 2021-01-15 生物控股有限公司 人胰岛淀粉样多肽(hiapp)特异性抗体及其用途
KR101956302B1 (ko) * 2016-11-30 2019-03-11 연세대학교 산학협력단 세포 내부 pH 감응성 융합 펩티드 및 이를 유효성분으로 포함하는 단백질의 비정상적인 응집 또는 미스폴딩과 관련된 질환을 예방 또는 치료하기 위한 약학 조성물
EP3664831B1 (de) * 2017-08-11 2023-06-14 University Of Kentucky Research Foundation Anti-neurodegenerative therapie und verwendung
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6344895A (ja) * 1986-08-13 1988-02-25 Kyowa Hakko Kogyo Co Ltd 抗アミロイドa蛋白質単クロ−ン性抗体
DE69408145T2 (de) * 1993-07-19 1998-09-03 Resolution Pharm Inc Hydrazine mit einer n3s konfiguration als radionukleide chelatoren
US6303567B1 (en) * 1995-03-14 2001-10-16 Praecis Pharmaceuticals, Inc . Modulators of β-amyloid peptide aggregation comprising D-amino acids
WO1998020135A2 (en) * 1996-11-06 1998-05-14 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Protease-activatable pseudomonas exotoxin a-like proproteins
JP2000193661A (ja) * 1998-12-25 2000-07-14 Tokyo Rika Kikai Kk 痴呆症の検査方法

Similar Documents

Publication Publication Date Title
JP2006506942A5 (de)
NZ621196A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
JP2008508859A5 (de)
JP2010516290A5 (de)
JP2009520758A5 (de)
JP2009519025A5 (de)
NZ591130A (en) Compositions comprising a PD-1 antagonists and cyclophosphamide and methods of use thereof
JP2019533722A5 (de)
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008998A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
JP2008530975A5 (de)
RU2007139915A (ru) Haemophilus influenzae типа в
JP2008521795A5 (de)
MX2008009493A (es) Peptido novedoso y uso del mismo.
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
JP2011518179A5 (de)
RU2013126581A (ru) Мутанты стрептокиназы и их ковалентно модифицированные формы
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
RU2010144014A (ru) Применение пегилированных вариантов ифр-i для лечения нейромышечных расстройств
RU2007115411A (ru) Пептиды hsp60 и их apl-производные и фармацевтические композиции
WO2006138745A3 (en) Therapeutic peptides and vaccines
JP2008531463A5 (de)
RU2001132140A (ru) Рекомбинантный рецептор коллагена на тромбоцитах гликопротеин VI и его применение в фармацевтике